Two for Two on The Analytical Scientist's Power List
Two from ASTech (Trajan's collaboration with UTAS and ARC) have graced The Analytical Scientist's Power Lists for two consecutive years:
- 2013 and 2014 - Emily Hilder, ASTech Training Centre Director; Professor and Head of Discipline, Chemistry, Australian Centre for Research on Separation Science (ACROSS), School of Physical Sciences, UTAS.
- 2014 - Michael Breadmore, ASTech Steering Committee Member; Professor and ARC Future Fellow, Australian Centre for Research on Separation Science (ACROSS), School of Physical Science, UTAS.
This could be you! Boost your postgraduate career at ASTech. Apply now.
Read more at The Analytical Scientist:
- The Power List 2014 - Top 40 under 40
- The Power List 2013 - Top 100 most influential analytical scientists
 have graced The Analytical Scientist's Power Lists for two consecutive years:
2013 and 2014 - Emily Hilder, ASTech Training Centre Director; Professor and Head of Discipline, ...&media=//cdn.shopify.com/s/files/1/0767/9441/articles/Parc_02_HR_aa439861-adc9-4415-87bb-69906986939a_600x.jpg?v=1452494990){kind=link}
Also in News
Advantages of hemaPEN blood microsampling validated for therapeutic drug monitoring in RSC’s Analyst
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.
European patent for Trajan’s hemaPEN
US FDA listing of Trajan’s hemaPEN blood microsampling device
Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.